65--Florbetaben F-18 Injection Amyloid Plaque RadioPharmaceutical
Overview
- Posted
- August 10, 2019
- Notice type
- Special Notice
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
Notice details
- PSC
- 65: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
- Last updated
- Dec 6, 2025
Identifiers
- Solicitation number
- 36C24819Q1344
- Notice ID
- 99a200cadc529a44b1732e302c3dd3ef
Description
This is not a solicitation for quotes. This is a notice of contract action (NOCA). The purpose of this NOCA is to provide notification of the Department of Veterans Affairs (VA) intent of contract action to make a sole source award in accordance with FAR Part 6.302-1. Notice of Contract Action: Network Contracting Office (NCO) 8 intends to issue a sole source, firm fixed price contract with a base year and four option years, using other than full and open competition, to SOFIE, Co. for the purchase of FDA approved Neuraceq Florbetaben F-18 Injections for the VA Healthcare Center Miami. Estimated value of this acquisition is approximately $110,000.00/year and $550,000/including base and option years. The estimated award date is on or before September 01, 2019. Qualified sources may submit a quote (or capabilities statement) which shall be considered but shall in no way bind the agency. Reimbursement will not be made for any costs associated with providing or requesting information in response to this NOCA. Responses shall be submitted via email to Deborah.Murphy3@va.gov and received no later than 12:00 PM Tuesday, August 20, 2019.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36C24819Q1344- Special NoticeCurrentAug 10, 2019
65--Florbetaben F-18 Injection Amyloid Plaque RadioPharmaceutical
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36C24819Q1344
Archive Date
Oct 9, 2019